Jove
Visualize
Contact Us

Related Experiment Videos

Achieving tobacco cessation: current status, current problems, future possibilities.

Laszlo T Vaszar1, Priscilla S A Sarinas, Glen A Lillington

  • 1Division of Pulmonary and Critical Care Medicine, Stanford University School of Medicine, Palo Alto, Calif., USA.

Respiration; International Review of Thoracic Diseases
|September 17, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Comparative performance of shape-sensing robotic-assisted bronchoscopy and CT-guided transthoracic biopsy in diagnosing peripheral pulmonary lesions.

Lung cancer (Amsterdam, Netherlands)·2026
Same author

Diagnostic performance of monarch robotic bronchoscopy with and without mobile cone-beam CT support.

Lung cancer (Amsterdam, Netherlands)·2026
Same author

Pathological features of connective tissue disease-associated interstitial lung disease in transbronchial cryobiopsies.

Histopathology·2024
Same author

Pragmatic Clinical Trials: The Ethics of Conducting Research in the Real World.

Mayo Clinic proceedings·2024
Same author

The Thoracic Research Evaluation and Treatment 2.0 Model: A Lung Cancer Prediction Model for Indeterminate Nodules Referred for Specialist Evaluation.

Chest·2023
Same author

Emotional Distress, Anxiety, and General Health Status in Patients With Newly Identified Small Pulmonary Nodules: Results From the Watch the Spot Trial.

Chest·2023
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Pharmacological aids like bupropion and nicotine therapy (NT) help reduce nicotine withdrawal symptoms for tobacco cessation. Combining these treatments increases effectiveness, though long-term abstinence rates require further research.

Area of Science:

  • Pharmacology
  • Addiction Medicine
  • Genetics

Background:

  • Tobacco cessation remains a significant challenge in public health.
  • Pharmacological interventions, including bupropion and nicotine therapy (NT), aid in achieving abstinence.
  • Current understanding of optimal clinical application for these therapies is incomplete.

Purpose of the Study:

  • To review the effectiveness of bupropion and NT in tobacco cessation.
  • To identify areas for improvement in current pharmacological cessation strategies.
  • To explore the role of genetics in nicotine dependence.

Main Methods:

  • Review of existing literature on bupropion and NT for smoking cessation.
  • Analysis of combination therapy versus monotherapy.

Related Experiment Videos

  • Examination of factors influencing abstinence rates and relapse.
  • Main Results:

    • Both bupropion and NT reduce nicotine withdrawal symptoms.
    • Combination therapy demonstrates greater effectiveness than monotherapy.
    • Higher doses of NT, with or without bupropion, increase effectiveness.
    • Initial quit rates are often below 50%, with a decline in abstinence post-therapy.

    Conclusions:

    • Pharmacological aids are beneficial but require further research for optimal use.
    • Investigating optimal dosing, duration, tapering, relapse prevention, and delivery methods for NT is crucial.
    • The genetic component of nicotine dependence warrants continued investigation.